These findings are consistent with previous reports suggesting that neuroendocrine differentiation—identified by the presence of markers such as chromogranin A, synaptophysin, and CD56—is associated with unfavorable outcomes in LCC. Here, SYP is linked to leukoencephalopathy with calcifications and cysts.